tiprankstipranks
Cormedix (CRMD)
NASDAQ:CRMD
US Market

Cormedix (CRMD) Technical Analysis

Compare
1,254 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
4Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Cormedix’s (CRMD) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Cormedix is a Buy.
Cormedix’s (CRMD) 20-Day exponential moving average is 10.67, while Cormedix’s (CRMD) share price is $10.82, making it a Buy.
Cormedix’s (CRMD) 50-Day exponential moving average is 10.39, while Cormedix’s (CRMD) share price is $10.82, making it a Buy.

Cormedix (CRMD) Pivot Points

Feb 21, 2025, 11:11 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.93
10.22
10.70
10.99
11.47
11.76
12.24
Fibonacci
10.22
10.51
10.70
10.99
11.28
11.47
11.76
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cormedix (CRMD) Moving Averages

Feb 21, 2025, 11:11 AM
Period
Simple
Exponential
MA5
10.71Buy
10.73Buy
MA10
10.46Buy
10.65Buy
MA20
10.87Sell
10.67Buy
MA50
10.10Buy
10.39Buy
MA100
10.22Buy
9.67Buy
MA200
7.70Buy
7.83Buy
Cormedix’s (CRMD) 10-Day exponential moving average is 10.65, while Cormedix’s (CRMD) share price is $10.82, making it a Buy.
Cormedix’s (CRMD) 100-Day exponential moving average is 9.67, while Cormedix’s (CRMD) share price is $10.82, making it a Buy.
Cormedix’s (CRMD) stock price is $10.82 and Cormedix’s (CRMD) 50-day simple moving average is 10.10, creating a Buy signal.
Cormedix’s (CRMD) stock price is $10.82 and Cormedix’s (CRMD) 100-day simple moving average is 10.22, creating a Buy signal.
Cormedix’s (CRMD) stock price is $10.82 and Cormedix’s (CRMD) 200-day simple moving average is 7.70, creating a Buy signal.

Cormedix (CRMD) Technical Indicators

Feb 21, 2025, 11:11 AM
Name
Value
Implied Action
RSI (14)
52.31
Neutral
STOCH (9,6)
81.06
Sell
STOCHRSI (14)
62.26
Neutral
MACD (12,26)
0.02
Buy
ADX (14)
17.96
Buy
Williams %R
-30.46
Buy
CCI (14)
-1.88
Neutral
ATR (14)
0.58
-
Ultimate Oscillator
56.23
Neutral
ROC
-1.37
Sell
Cormedix’s (CRMD) Relative Strength Index (RSI) is 52.31, creating a Neutral signal.
Cormedix’s (CRMD) Trend Strength Indicator (ADX) is 17.96, creating a Buy signal.
Cormedix’s (CRMD) Commodity Channel Index (CCI) is -1.88, creating a Neutral signal.
Cormedix’s (CRMD) Price Rate of Change (ROC) is -1.37, creating a Sell signal.

FAQ

Is CRMD a Buy, Hold, or Sell?
Based on CRMD’s technical indicators, CRMD is a Strong Buy.
    What is CRMD’s RSI (14)?
    CRMD’s RSI (14) is 52.31, which suggests CRMD is a Neutral.
      What is CRMD’s MACD?
      CRMD’s MACD is 0.02, which suggests CRMD is a Buy.
        What is CRMD’s 5-day moving average?
        CRMD’s 5-day moving average is 10.71, which suggests CRMD is a Buy.
          What is CRMD’s 20-day moving average?
          CRMD 20-day moving average is 10.87, which suggests CRMD is a Sell.
            What is CRMD’s 50-day moving average?
            CRMD’s 50-day moving average is 10.10, which suggests CRMD is a Buy.
              What is CRMD’s 200-day moving average?
              CRMD’s 200-day moving average is 7.70, which suggests CRMD is a Buy.
                What is CRMD’s Williams % R (14)?
                CRMD’s Williams % R (14) is -30.46, which suggests CRMD is a Buy.
                  What is CRMD’s CCI (14)?
                  CRMD’s CCI (14) is -1.88, which suggests CRMD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis